What is NDC 65862-237?

65862-237 is the product NDC for Ibandronate Sodium, Ibandronate sodium 150 mg/1 tablet, film coated, listed with the FDA by Aurobindo Pharma Limited. It has 1 package NDC, shown above in 10- and 11-digit form.

Aurobindo Pharma Limited, NDC labeler code 65862. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Ibandronate Sodium?

8 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Ibandronate Sodium NDC 65862-237 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)65862-237Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65862-0237Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
65862-237-03	6586202370365862023703	1 BLISTER PACK in 1 CARTON (65862-237-03) / 3 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Mar 11, 2016

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ibandronate Sodium
Generic name (nonproprietary): ibandronate sodium
Active ingredients: Ibandronate sodium — 150 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Aurobindo Pharma LimitedNDC labeler code 65862
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204502
Marketing start: Mar 11, 2016
Listing expires: Dec 31, 2027
Other FDA classes: Diphosphonates (Chemical structure)
Identifiers: Product ID 65862-237_ac6119dd-ca9a-4a6e-9a3b-4ddb60924abeSPL ID ac6119dd-ca9a-4a6e-9a3b-4ddb60924abeSPL set ID 86c0b4ae-5e38-4efe-88af-50ac560e294fRxCUI 904932UNII J12U072QL0
Pharmacologic class: Bisphosphonate

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465862023703 followed by a unit qualifier and the quantity

Package 65862-0237-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 18, 2026.

Indications (excerpt from the label)

Ibandronate sodium is a bisphosphonate indicated for the treatment and prevention of postmenopausal osteoporosis. ( 1.1 ) Limitations of Use The optimal duration of use has not been determined. For patients at low -risk for fracture, consider drug discontinuation after 3 to 5 years of use. ( 1.2 ) 1.1 Treatment and Prevention of Postmenopausal Osteoporosis Ibandronate sodium tablets are indicated for the treatment and prevention of osteoporosis in postmenopausal women. Ibandronate sodium tablets increase bone mineral density (BMD) and reduce the incidence of vertebral fractures. 1.2 Important Limitations of Use The optimal duration of use has not been determined. The safety and effectiveness…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 65862-237

What is NDC 65862-237?: 65862-237 is the product NDC for Ibandronate Sodium, Ibandronate sodium 150 mg/1 tablet, film coated, listed with the FDA by Aurobindo Pharma Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Ibandronate Sodium.
What is the active ingredient?: Ibandronate sodium.
Who is the labeler?: Aurobindo Pharma Limited, NDC labeler code 65862. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Ibandronate Sodium?: 8 other product NDCs are listed under this name. See all Ibandronate Sodium NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Ibandronate Sodium NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Ibandronate Sodium	Ibandronate sodium 150 mg/1	TabletOral	Bionpharma Inc.	69452-378	69452-0378-74
Ibandronate Sodium	Ibandronate sodium 150 mg/1	Tablet, Film coatedOral	Macleods Pharmaceuticals Limited	33342-150	33342-0150-5233342-0150-53
Ibandronate Sodium	Ibandronate sodium 3 mg/3mL	InjectionIntravenous	Apotex Corp.	60505-6097	60505-6097-00
Ibandronate Sodium	Ibandronate sodium 3 mg/3mL	Injection, SolutionIntravenous	Eugia US LLC	55150-191	55150-0191-83
Ibandronate Sodium	Ibandronate sodium 3 mg/3mL	Injection, SolutionIntravenous	Sun Pharmaceutical Industries, Inc.	62756-218	62756-0218-40
Ibandronate sodium	Ibandronate sodium 150 mg/1	TabletOral	A-S Medication Solutions	50090-7654	50090-7654-00
Ibandronate sodium	Ibandronate sodium 150 mg/1	TabletOral	Dr. Reddy's Laboratories Limited	55111-575	55111-0575-0355111-0575-43
Ibandronate Sodium	Ibandronate sodium 150 mg/1	Tablet, Film coatedOral	Golden State Medical Supply, Inc.	60429-643	60429-0643-73